{"product_id":"tudca-100x500mg","title":"TUDCA 100x500mg","description":"\u003cp data-end=\"657\" data-start=\"67\"\u003e                                        \u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003eNOT FOR HUMAN CONSUMPTION\u003c\/span\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-end=\"657\" data-start=\"67\"\u003e\u003cstrong\u003eTUDCA\u003c\/strong\u003e is the \u003cstrong data-end=\"171\" data-start=\"113\"\u003etaurine-conjugated form of ursodeoxycholic acid (UDCA)\u003c\/strong\u003e—a hydrophilic, cytoprotective \u003cstrong data-end=\"215\" data-start=\"202\"\u003ebile acid\u003c\/strong\u003e that acts as a \u003cstrong data-end=\"253\" data-start=\"231\"\u003echemical chaperone\u003c\/strong\u003e to relieve \u003cstrong data-end=\"302\" data-start=\"265\"\u003eendoplasmic-reticulum (ER) stress\u003c\/strong\u003e, stabilizes \u003cstrong data-end=\"331\" data-start=\"315\"\u003emitochondria\u003c\/strong\u003e (anti-apoptotic), and modulates \u003cstrong data-end=\"387\" data-start=\"364\"\u003ebile-acid receptors\u003c\/strong\u003e (notably \u003cstrong data-end=\"405\" data-start=\"397\"\u003eTGR5\u003c\/strong\u003e; very weak FXR activity). Clinically, UDCA is widely used for \u003cstrong data-end=\"497\" data-start=\"468\"\u003echolestatic liver disease\u003c\/strong\u003e; \u003cstrong data-end=\"508\" data-start=\"499\"\u003eTUDCA\u003c\/strong\u003e is available as a drug in some countries and as a \u003cstrong data-end=\"573\" data-start=\"559\"\u003esupplement\u003c\/strong\u003e in others. Interest spans \u003cstrong data-end=\"644\" data-start=\"600\"\u003eliver, metabolic, neurologic, and ocular\u003c\/strong\u003e indications.\u003c\/p\u003e\n\u003chr data-end=\"662\" data-start=\"659\"\u003e\n\u003ch3 data-end=\"720\" data-start=\"664\"\u003eAdditional Benefits of TUDCA Now Under Investigation\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"group _tableWrapper_1rjym_13 flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"3164\" data-start=\"722\"\u003e\n\u003cthead data-end=\"750\" data-start=\"722\"\u003e\n\u003ctr data-end=\"750\" data-start=\"722\"\u003e\n\u003cth data-col-size=\"md\" data-end=\"732\" data-start=\"722\"\u003eBenefit\u003c\/th\u003e\n\u003cth data-col-size=\"xl\" data-end=\"750\" data-start=\"732\"\u003eKey take-aways\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"3164\" data-start=\"761\"\u003e\n\u003ctr data-end=\"1035\" data-start=\"761\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"788\" data-start=\"761\"\u003e\u003cstrong data-end=\"787\" data-start=\"763\"\u003e1 NAFLD\/MASH support\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1035\" data-start=\"788\"\u003eSmall RCTs and pilots show \u003cstrong data-end=\"839\" data-start=\"817\"\u003eALT\/AST reductions\u003c\/strong\u003e, \u003cstrong data-end=\"873\" data-start=\"841\"\u003eMRI-PDFF liver-fat decreases\u003c\/strong\u003e, and improved \u003cstrong data-end=\"911\" data-start=\"888\"\u003einsulin sensitivity\u003c\/strong\u003e—likely via ER-stress relief and improved hepatocellular bile-acid handling. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Hepatology; Liver International\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1356\" data-start=\"1036\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1071\" data-start=\"1036\"\u003e\u003cstrong data-end=\"1070\" data-start=\"1038\"\u003e2 Cholestatic cytoprotection\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1356\" data-start=\"1071\"\u003eIntrahepatic cholestasis and drug-induced cholestasis models show \u003cstrong data-end=\"1171\" data-start=\"1139\"\u003ereduced hepatocyte apoptosis\u003c\/strong\u003eand better cholestatic labs; human data are strongest for \u003cstrong data-end=\"1238\" data-start=\"1230\"\u003eUDCA\u003c\/strong\u003e, with \u003cstrong data-end=\"1254\" data-start=\"1245\"\u003eTUDCA\u003c\/strong\u003e as mechanistic adjunct. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Journal of Hepatology; Alimentary Pharmacology \u0026amp; Therapeutics\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1648\" data-start=\"1357\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1397\" data-start=\"1357\"\u003e\u003cstrong data-end=\"1396\" data-start=\"1359\"\u003e3 Neurodegeneration (ALS, PD, HD)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1648\" data-start=\"1397\"\u003eTUDCA crosses the BBB; multiple early-\/mid-phase studies suggest \u003cstrong data-end=\"1493\" data-start=\"1464\"\u003eslower functional decline\u003c\/strong\u003e or biomarker improvement in ALS\/Parkinson’s\/Huntington’s; larger confirmatory trials are mixed but ongoing. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Neurology; Annals of Neurology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1869\" data-start=\"1649\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1685\" data-start=\"1649\"\u003e\u003cstrong data-end=\"1684\" data-start=\"1651\"\u003e4 Diabetes\/insulin resistance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1869\" data-start=\"1685\"\u003eIn obese\/insulin-resistant adults, TUDCA \u003cstrong data-end=\"1781\" data-start=\"1728\"\u003eimproves hepatic and peripheral insulin signaling\u003c\/strong\u003e (↑ insulin sensitivity) and lowers inflammatory markers. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Diabetes; JCEM\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2162\" data-start=\"1870\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1904\" data-start=\"1870\"\u003e\u003cstrong data-end=\"1903\" data-start=\"1872\"\u003e5 Retinal\/ocular protection\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2162\" data-start=\"1904\"\u003eIn retinitis-pigmentosa and diabetic-retinopathy models, TUDCA \u003cstrong data-end=\"2004\" data-start=\"1969\"\u003ereduces photoreceptor apoptosis\u003c\/strong\u003e and preserves ERG function; small human feasibility work is underway. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Investigative Ophthalmology \u0026amp; Visual Science; Experimental Eye Research\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2385\" data-start=\"2163\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2208\" data-start=\"2163\"\u003e\u003cstrong data-end=\"2207\" data-start=\"2165\"\u003e6 Bariatric\/metabolic surgery adjuvant\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2385\" data-start=\"2208\"\u003eMay \u003cstrong data-end=\"2255\" data-start=\"2214\"\u003eattenuate post-operative liver stress\u003c\/strong\u003e and improve bile-acid pool hydrophilicity; mechanistic\/biomarker signals predominate. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Obesity Surgery; Metabolism\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2631\" data-start=\"2386\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2435\" data-start=\"2386\"\u003e\u003cstrong data-end=\"2434\" data-start=\"2388\"\u003e7 Mitochondrial disease \u0026amp; myopathy signals\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2631\" data-start=\"2435\"\u003eAnti-apoptotic and mitochondrial-stabilizing actions (↓ Bax translocation, ↓ cytochrome-c release) show functional benefits in models. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Cell Death \u0026amp; Disease; Journal of Physiology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2863\" data-start=\"2632\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2665\" data-start=\"2632\"\u003e\u003cstrong data-end=\"2664\" data-start=\"2634\"\u003e8 Gut barrier \u0026amp; microbiome\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2863\" data-start=\"2665\"\u003eHydrophilic bile-acid enrichment can \u003cstrong data-end=\"2728\" data-start=\"2704\"\u003ereduce bile toxicity\u003c\/strong\u003e, improve \u003cstrong data-end=\"2768\" data-start=\"2738\"\u003eintestinal tight junctions\u003c\/strong\u003e, and favorably shift \u003cstrong data-end=\"2814\" data-start=\"2790\"\u003ebile-acid–microbiota\u003c\/strong\u003e crosstalk. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Gut; Gastroenterology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3164\" data-start=\"2864\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2913\" data-start=\"2864\"\u003e\u003cstrong data-end=\"2912\" data-start=\"2866\"\u003e9 Drug-induced liver injury (DILI) adjunct\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"3164\" data-start=\"2913\"\u003eCase series and small studies suggest \u003cstrong data-end=\"2984\" data-start=\"2953\"\u003efaster enzyme normalization\u003c\/strong\u003e in selected cholestatic DILI phenotypes (evidence still preliminary; UDCA remains the reference). \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Hepatology Communications; Clinical Gastroenterology \u0026amp; Hepatology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"3169\" data-start=\"3166\"\u003e\n\u003ch2 data-end=\"3206\" data-start=\"3171\"\u003e2. Molecular Mechanism of Action\u003c\/h2\u003e\n\u003ch3 data-end=\"3234\" data-start=\"3208\"\u003e2.1 Pharmacodynamics\u003c\/h3\u003e\n\u003cul data-end=\"3922\" data-start=\"3235\"\u003e\n\u003cli data-end=\"3431\" data-start=\"3235\"\u003e\n\u003cp data-end=\"3431\" data-start=\"3237\"\u003e\u003cstrong data-end=\"3272\" data-start=\"3237\"\u003eER-stress “chemical chaperone”:\u003c\/strong\u003e TUDCA stabilizes protein folding, \u003cstrong data-end=\"3357\" data-start=\"3307\"\u003enormalizes the unfolded-protein response (UPR)\u003c\/strong\u003e (PERK\/eIF2α, IRE1\/XBP1, ATF6), and \u003cstrong data-end=\"3428\" data-start=\"3393\"\u003ereduces CHOP-mediated apoptosis\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3583\" data-start=\"3432\"\u003e\n\u003cp data-end=\"3583\" data-start=\"3434\"\u003e\u003cstrong data-end=\"3463\" data-start=\"3434\"\u003eMitochondrial protection:\u003c\/strong\u003e Inhibits \u003cstrong data-end=\"3480\" data-start=\"3473\"\u003eBax\u003c\/strong\u003e activation\/translocation, preserves \u003cstrong data-end=\"3524\" data-start=\"3517\"\u003eΔΨm\u003c\/strong\u003e, reduces \u003cstrong data-end=\"3541\" data-start=\"3534\"\u003eROS\u003c\/strong\u003e, and limits \u003cstrong data-end=\"3569\" data-start=\"3554\"\u003ecaspase-9\/3\u003c\/strong\u003e activation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3785\" data-start=\"3584\"\u003e\n\u003cp data-end=\"3785\" data-start=\"3586\"\u003e\u003cstrong data-end=\"3610\" data-start=\"3586\"\u003eBile-acid signaling:\u003c\/strong\u003e Predominantly \u003cstrong data-end=\"3641\" data-start=\"3625\"\u003eTGR5 agonism\u003c\/strong\u003e (↑ cAMP; GLP-1 and energy-expenditure signals in some tissues); \u003cstrong data-end=\"3729\" data-start=\"3706\"\u003eminimal FXR agonism\u003c\/strong\u003e compared with chenodeoxycholic acid\/obeticholic acid.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3922\" data-start=\"3786\"\u003e\n\u003cp data-end=\"3922\" data-start=\"3788\"\u003e\u003cstrong data-end=\"3816\" data-start=\"3788\"\u003eMembrane\/cytoprotection:\u003c\/strong\u003e Renders the bile-acid pool \u003cstrong data-end=\"3864\" data-start=\"3844\"\u003emore hydrophilic\u003c\/strong\u003e, reducing detergent injury to hepatocytes\/cholangiocytes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-end=\"3951\" data-start=\"3924\"\u003e2.2 Down-stream Biology\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"group _tableWrapper_1rjym_13 flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"4389\" data-start=\"3953\"\u003e\n\u003cthead data-end=\"3995\" data-start=\"3953\"\u003e\n\u003ctr data-end=\"3995\" data-start=\"3953\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3963\" data-start=\"3953\"\u003ePathway\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"3984\" data-start=\"3963\"\u003eFunctional outcome\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3995\" data-start=\"3984\"\u003eContext\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"4389\" data-start=\"4010\"\u003e\n\u003ctr data-end=\"4102\" data-start=\"4010\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4049\" data-start=\"4010\"\u003e\u003cstrong data-end=\"4048\" data-start=\"4012\"\u003eUPR rebalancing (PERK\/IRE1\/ATF6)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4076\" data-start=\"4049\"\u003e↓ ER-stress, ↓ apoptosis\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4102\" data-start=\"4076\"\u003eLiver, β-cell, neurons\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4197\" data-start=\"4103\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4137\" data-start=\"4103\"\u003e\u003cstrong data-end=\"4136\" data-start=\"4105\"\u003eBax–caspase axis inhibition\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4165\" data-start=\"4137\"\u003eMitochondrial integrity ↑\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4197\" data-start=\"4165\"\u003eHepatocyte\/neuronal survival\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4301\" data-start=\"4198\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4219\" data-start=\"4198\"\u003e\u003cstrong data-end=\"4218\" data-start=\"4200\"\u003eTGR5 signaling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4265\" data-start=\"4219\"\u003eGLP-1 ↑, thermogenic\/anti-inflammatory cues\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4301\" data-start=\"4265\"\u003eEnteroendocrine, adipose, immune\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4389\" data-start=\"4302\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4338\" data-start=\"4302\"\u003e\u003cstrong data-end=\"4337\" data-start=\"4304\"\u003eBile-acid pool hydrophilicity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"4361\" data-start=\"4338\"\u003eCholestatic injury ↓\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4389\" data-start=\"4361\"\u003eLiver\/biliary epithelium\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"4394\" data-start=\"4391\"\u003e\n\u003ch2 data-end=\"4418\" data-start=\"4396\"\u003e3. Pharmacokinetics\u003c\/h2\u003e\n\u003cul data-end=\"4930\" data-start=\"4420\"\u003e\n\u003cli data-end=\"4495\" data-start=\"4420\"\u003e\n\u003cp data-end=\"4495\" data-start=\"4422\"\u003e\u003cstrong data-end=\"4432\" data-start=\"4422\"\u003eRoute:\u003c\/strong\u003e Oral (capsules, tablets); also IV in some research settings.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4588\" data-start=\"4496\"\u003e\n\u003cp data-end=\"4588\" data-start=\"4498\"\u003e\u003cstrong data-end=\"4513\" data-start=\"4498\"\u003eAbsorption:\u003c\/strong\u003e Variable; enhanced with food; undergoes \u003cstrong data-end=\"4585\" data-start=\"4554\"\u003eenterohepatic recirculation\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4679\" data-start=\"4589\"\u003e\n\u003cp data-end=\"4679\" data-start=\"4591\"\u003e\u003cstrong data-end=\"4608\" data-start=\"4591\"\u003eDistribution:\u003c\/strong\u003e Concentrates in \u003cstrong data-end=\"4643\" data-start=\"4625\"\u003ebile and liver\u003c\/strong\u003e; modest CNS penetration reported.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4797\" data-start=\"4680\"\u003e\n\u003cp data-end=\"4797\" data-start=\"4682\"\u003e\u003cstrong data-end=\"4697\" data-start=\"4682\"\u003eMetabolism:\u003c\/strong\u003e Bile-salt transporters mediate cycling; \u003cstrong data-end=\"4780\" data-start=\"4738\"\u003eintestinal deconjugation\/reconjugation\u003c\/strong\u003e by microbiota.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4930\" data-start=\"4798\"\u003e\n\u003cp data-end=\"4930\" data-start=\"4800\"\u003e\u003cstrong data-end=\"4814\" data-start=\"4800\"\u003eHalf-life:\u003c\/strong\u003e Several hours with \u003cstrong data-end=\"4848\" data-start=\"4834\"\u003emulti-peak\u003c\/strong\u003e profile due to recirculation; functional exposure persists with divided dosing.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"4935\" data-start=\"4932\"\u003e\n\u003ch2 data-end=\"4973\" data-start=\"4937\"\u003e4. Clinical Evidence (high-level)\u003c\/h2\u003e\n\u003cul data-end=\"5741\" data-start=\"4975\"\u003e\n\u003cli data-end=\"5133\" data-start=\"4975\"\u003e\n\u003cp data-end=\"5133\" data-start=\"4977\"\u003e\u003cstrong data-end=\"4992\" data-start=\"4977\"\u003eNAFLD\/MASH:\u003c\/strong\u003e Small RCTs\/controlled studies show \u003cstrong data-end=\"5068\" data-start=\"5028\"\u003eenzyme and fat-fraction improvements\u003c\/strong\u003e; histologic endpoints remain limited vs lifestyle\/GLP-1 class.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5331\" data-start=\"5134\"\u003e\n\u003cp data-end=\"5331\" data-start=\"5136\"\u003e\u003cstrong data-end=\"5160\" data-start=\"5136\"\u003eCholestatic disease:\u003c\/strong\u003e Strongest human evidence still favors \u003cstrong data-end=\"5207\" data-start=\"5199\"\u003eUDCA\u003c\/strong\u003e as standard; TUDCA provides \u003cstrong data-end=\"5259\" data-start=\"5236\"\u003emechanistic overlap\u003c\/strong\u003e and is used regionally; head-to-head outcome superiority is unproven.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5482\" data-start=\"5332\"\u003e\n\u003cp data-end=\"5482\" data-start=\"5334\"\u003e\u003cstrong data-end=\"5357\" data-start=\"5334\"\u003eType 2 diabetes\/IR:\u003c\/strong\u003e Proof-of-concept studies demonstrate \u003cstrong data-end=\"5427\" data-start=\"5395\"\u003eimproved insulin sensitivity\u003c\/strong\u003e (clamp data) and \u003cstrong data-end=\"5479\" data-start=\"5445\"\u003einflammatory\/oxidative markers\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5654\" data-start=\"5483\"\u003e\n\u003cp data-end=\"5654\" data-start=\"5485\"\u003e\u003cstrong data-end=\"5495\" data-start=\"5485\"\u003eNeuro:\u003c\/strong\u003e ALS\/PD\/HD trials show \u003cstrong data-end=\"5529\" data-start=\"5518\"\u003esignals\u003c\/strong\u003e (slower functional decline\/biomarkers) but mixed outcomes in larger programs; research continues (including combinations).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5741\" data-start=\"5655\"\u003e\n\u003cp data-end=\"5741\" data-start=\"5657\"\u003e\u003cstrong data-end=\"5665\" data-start=\"5657\"\u003eEye:\u003c\/strong\u003e Human data are early; robust animal protection against photoreceptor death.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cblockquote data-end=\"5934\" data-start=\"5743\"\u003e\n\u003cp data-end=\"5934\" data-start=\"5745\"\u003e\u003cstrong data-end=\"5771\" data-start=\"5745\"\u003eEvidence quality note:\u003c\/strong\u003e Solid \u003cstrong data-end=\"5811\" data-start=\"5778\"\u003emechanistic and translational\u003c\/strong\u003e base; \u003cstrong data-end=\"5845\" data-start=\"5818\"\u003emoderate human evidence\u003c\/strong\u003e for metabolic and hepatobiliary endpoints; \u003cstrong data-end=\"5910\" data-start=\"5889\"\u003eemerging\/variable\u003c\/strong\u003e in neuro\/ocular fields.\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003chr data-end=\"5939\" data-start=\"5936\"\u003e\n\u003ch2 data-end=\"5993\" data-start=\"5941\"\u003e5. Practical Use (research \u0026amp; real-world patterns)\u003c\/h2\u003e\n\u003cul data-end=\"6519\" data-start=\"5995\"\u003e\n\u003cli data-end=\"6102\" data-start=\"5995\"\u003e\n\u003cp data-end=\"6102\" data-start=\"5997\"\u003e\u003cstrong data-end=\"6023\" data-start=\"5997\"\u003eDoses used in studies:\u003c\/strong\u003e \u003cstrong data-end=\"6044\" data-start=\"6024\"\u003e250–1,500 mg\/day\u003c\/strong\u003e, often \u003cstrong data-end=\"6071\" data-start=\"6052\"\u003e10–15 mg\/kg\/day\u003c\/strong\u003e in divided doses with meals.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6246\" data-start=\"6103\"\u003e\n\u003cp data-end=\"6246\" data-start=\"6105\"\u003e\u003cstrong data-end=\"6142\" data-start=\"6105\"\u003eUse cases (off-label\/supplement):\u003c\/strong\u003e NAFLD\/MASH adjunct, metabolic syndrome\/IR, cholestatic tendencies, “neuro-support” (investigational).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6519\" data-start=\"6247\"\u003e\n\u003cp data-end=\"6279\" data-start=\"6249\"\u003e\u003cstrong data-end=\"6277\" data-start=\"6249\"\u003eStacking considerations:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"6519\" data-start=\"6282\"\u003e\n\u003cli data-end=\"6417\" data-start=\"6282\"\u003e\n\u003cp data-end=\"6417\" data-start=\"6284\"\u003e\u003cstrong data-end=\"6304\" data-start=\"6284\"\u003eLiver\/metabolic:\u003c\/strong\u003e Diet + exercise, \u003cstrong data-end=\"6353\" data-start=\"6322\"\u003eweight-loss pharmacotherapy\u003c\/strong\u003e if indicated; \u003cstrong data-end=\"6381\" data-start=\"6368\"\u003evitamin D\u003c\/strong\u003e, \u003cstrong data-end=\"6394\" data-start=\"6383\"\u003eomega-3\u003c\/strong\u003e; avoid hepatotoxins.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6519\" data-start=\"6420\"\u003e\n\u003cp data-end=\"6519\" data-start=\"6422\"\u003e\u003cstrong data-end=\"6432\" data-start=\"6422\"\u003eNeuro:\u003c\/strong\u003e Antioxidants\/mitochondrial supports are investigational; avoid claims beyond evidence.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"6524\" data-start=\"6521\"\u003e\n\u003ch2 data-end=\"6555\" data-start=\"6526\"\u003e6. Safety and Tolerability\u003c\/h2\u003e\n\u003cul data-end=\"7293\" data-start=\"6557\"\u003e\n\u003cli data-end=\"6679\" data-start=\"6557\"\u003e\n\u003cp data-end=\"6679\" data-start=\"6559\"\u003e\u003cstrong data-end=\"6570\" data-start=\"6559\"\u003eCommon:\u003c\/strong\u003e \u003cstrong data-end=\"6583\" data-start=\"6571\"\u003eGI upset\u003c\/strong\u003e, soft stools\/diarrhea, mild nausea; usually dose-related and improved with food\/split dosing.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6732\" data-start=\"6680\"\u003e\n\u003cp data-end=\"6732\" data-start=\"6682\"\u003e\u003cstrong data-end=\"6698\" data-start=\"6682\"\u003eLess common:\u003c\/strong\u003e Pruritus, headache, flatulence.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6810\" data-start=\"6733\"\u003e\n\u003cp data-end=\"6810\" data-start=\"6735\"\u003e\u003cstrong data-end=\"6754\" data-start=\"6735\"\u003eRare\/uncertain:\u003c\/strong\u003e Biliary colic in gallstone formers (theoretic), rash.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6985\" data-start=\"6811\"\u003e\n\u003cp data-end=\"6985\" data-start=\"6813\"\u003e\u003cstrong data-end=\"6835\" data-start=\"6813\"\u003eDrug interactions:\u003c\/strong\u003e May interact with \u003cstrong data-end=\"6880\" data-start=\"6854\"\u003ebile-acid sequestrants\u003c\/strong\u003e (reduced absorption—separate by ≥4 h). Monitor with \u003cstrong data-end=\"6945\" data-start=\"6933\"\u003ewarfarin\u003c\/strong\u003e if large liver-function shifts occur.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7154\" data-start=\"6986\"\u003e\n\u003cp data-end=\"7154\" data-start=\"6988\"\u003e\u003cstrong data-end=\"7012\" data-start=\"6988\"\u003eSpecial populations:\u003c\/strong\u003e Pregnancy—UDCA is standard for \u003cstrong data-end=\"7085\" data-start=\"7044\"\u003eintrahepatic cholestasis of pregnancy\u003c\/strong\u003e; specific \u003cstrong data-end=\"7105\" data-start=\"7096\"\u003eTUDCA\u003c\/strong\u003edata are more limited—defer to local guidance.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7293\" data-start=\"7155\"\u003e\n\u003cp data-end=\"7293\" data-start=\"7157\"\u003e\u003cstrong data-end=\"7178\" data-start=\"7157\"\u003eLong-term safety:\u003c\/strong\u003e Generally favorable in published series; monitor \u003cstrong data-end=\"7236\" data-start=\"7228\"\u003eLFTs\u003c\/strong\u003e, \u003cstrong data-end=\"7248\" data-start=\"7238\"\u003elipids\u003c\/strong\u003e, and \u003cstrong data-end=\"7267\" data-start=\"7254\"\u003eglycaemia\u003c\/strong\u003e in metabolic indications.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"7347\" data-start=\"7295\"\u003e\u003cstrong data-end=\"7347\" data-start=\"7295\"\u003eComparative matrix (bile-acid \u0026amp; adjunct options)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"group _tableWrapper_1rjym_13 flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"7932\" data-start=\"7349\"\u003e\n\u003cthead data-end=\"7452\" data-start=\"7349\"\u003e\n\u003ctr data-end=\"7452\" data-start=\"7349\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"7359\" data-start=\"7349\"\u003eFeature\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"7371\" data-start=\"7359\"\u003e\u003cstrong data-end=\"7370\" data-start=\"7361\"\u003eTUDCA\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"7382\" data-start=\"7371\"\u003e\u003cstrong data-end=\"7381\" data-start=\"7373\"\u003eUDCA\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"7419\" data-start=\"7382\"\u003e\u003cstrong data-end=\"7418\" data-start=\"7384\"\u003eObeticholic acid (FXR agonist)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"7452\" data-start=\"7419\"\u003e\u003cstrong data-end=\"7450\" data-start=\"7421\"\u003eGLP-1RA (metabolic NAFLD)\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"7932\" data-start=\"7475\"\u003e\n\u003ctr data-end=\"7626\" data-start=\"7475\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7492\" data-start=\"7475\"\u003ePrimary action\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7535\" data-start=\"7492\"\u003eER-stress relief, TGR5, hydrophilic bile\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7570\" data-start=\"7535\"\u003eHydrophilic bile, cytoprotection\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7595\" data-start=\"7570\"\u003ePotent \u003cstrong data-end=\"7586\" data-start=\"7579\"\u003eFXR\u003c\/strong\u003e agonism\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7626\" data-start=\"7595\"\u003eWeight loss, insulinotropic\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7741\" data-start=\"7627\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7647\" data-start=\"7627\"\u003eNAFLD enzymes\/fat\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7671\" data-start=\"7647\"\u003e\u003cstrong data-end=\"7670\" data-start=\"7649\"\u003eImproves (modest)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7680\" data-start=\"7671\"\u003eModest\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7711\" data-start=\"7680\"\u003eImproves but pruritus\/lipids\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7741\" data-start=\"7711\"\u003e\u003cstrong data-end=\"7739\" data-start=\"7713\"\u003eStrong via weight loss\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7850\" data-start=\"7742\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7765\" data-start=\"7742\"\u003eCholestasis evidence\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7776\" data-start=\"7765\"\u003eEmerging\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7800\" data-start=\"7776\"\u003e\u003cstrong data-end=\"7799\" data-start=\"7778\"\u003eStrong (standard)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7829\" data-start=\"7800\"\u003ePBC indication; pruritus ↑\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7850\" data-start=\"7829\"\u003eIndirect (weight)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7932\" data-start=\"7851\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7866\" data-start=\"7851\"\u003eGI tolerance\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7888\" data-start=\"7866\"\u003eGood (loose stools)\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7895\" data-start=\"7888\"\u003eGood\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7915\" data-start=\"7895\"\u003ePruritus ↑, LDL ↑\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7932\" data-start=\"7915\"\u003eNausea common\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"7937\" data-start=\"7934\"\u003e\n\u003ch2 data-end=\"7965\" data-start=\"7939\"\u003e7. Regulatory Landscape\u003c\/h2\u003e\n\u003cul data-end=\"8330\" data-start=\"7967\"\u003e\n\u003cli data-end=\"8108\" data-start=\"7967\"\u003e\n\u003cp data-end=\"8108\" data-start=\"7969\"\u003e\u003cstrong data-end=\"7980\" data-start=\"7969\"\u003eStatus:\u003c\/strong\u003e UDCA is widely approved; \u003cstrong data-end=\"8015\" data-start=\"8006\"\u003eTUDCA\u003c\/strong\u003e is approved in some regions and sold as \u003cstrong data-end=\"8078\" data-start=\"8056\"\u003edietary supplement\u003c\/strong\u003e in others (quality varies).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8217\" data-start=\"8109\"\u003e\n\u003cp data-end=\"8217\" data-start=\"8111\"\u003e\u003cstrong data-end=\"8127\" data-start=\"8111\"\u003eIndications:\u003c\/strong\u003e Vary by country; many uses (NAFLD, neuro, ocular) remain \u003cstrong data-end=\"8214\" data-start=\"8185\"\u003eoff-label\/investigational\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8330\" data-start=\"8218\"\u003e\n\u003cp data-end=\"8330\" data-start=\"8220\"\u003e\u003cstrong data-end=\"8237\" data-start=\"8220\"\u003eQuality note:\u003c\/strong\u003e If using supplement routes, prefer \u003cstrong data-end=\"8290\" data-start=\"8273\"\u003eGMP-certified\u003c\/strong\u003e suppliers with \u003cstrong data-end=\"8329\" data-start=\"8306\"\u003ethird-party testing\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"8335\" data-start=\"8332\"\u003e\n\u003ch2 data-end=\"8360\" data-start=\"8337\"\u003e8. Future Directions\u003c\/h2\u003e\n\u003cul data-end=\"8909\" data-start=\"8362\"\u003e\n\u003cli data-end=\"8467\" data-start=\"8362\"\u003e\n\u003cp data-end=\"8467\" data-start=\"8364\"\u003e\u003cstrong data-end=\"8387\" data-start=\"8364\"\u003eHead-to-head trials\u003c\/strong\u003e: TUDCA vs UDCA in cholestasis; combination with \u003cstrong data-end=\"8449\" data-start=\"8436\"\u003eGLP-1\/GIP\u003c\/strong\u003e agents in MASH.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8571\" data-start=\"8468\"\u003e\n\u003cp data-end=\"8571\" data-start=\"8470\"\u003e\u003cstrong data-end=\"8498\" data-start=\"8470\"\u003eBiomarker-guided therapy\u003c\/strong\u003e: ER-stress signatures, bile-acidomics, and \u003cstrong data-end=\"8558\" data-start=\"8542\"\u003eMRI-PDFF\/MRE\u003c\/strong\u003e endpoints.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8679\" data-start=\"8572\"\u003e\n\u003cp data-end=\"8679\" data-start=\"8574\"\u003e\u003cstrong data-end=\"8590\" data-start=\"8574\"\u003eNeuro trials\u003c\/strong\u003e: Larger, longer ALS\/PD studies; combination regimens (mitochondrial\/anti-excitotoxic).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8798\" data-start=\"8680\"\u003e\n\u003cp data-end=\"8798\" data-start=\"8682\"\u003e\u003cstrong data-end=\"8705\" data-start=\"8682\"\u003eFormulation science\u003c\/strong\u003e: \u003cstrong data-end=\"8725\" data-start=\"8707\"\u003eEnteric-coated\u003c\/strong\u003e and \u003cstrong data-end=\"8752\" data-start=\"8730\"\u003econtrolled-release\u003c\/strong\u003e to optimize delivery and reduce GI effects.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8909\" data-start=\"8799\"\u003e\n\u003cp data-end=\"8909\" data-start=\"8801\"\u003e\u003cstrong data-end=\"8823\" data-start=\"8801\"\u003eMicrobiome synergy\u003c\/strong\u003e: Pairing with \u003cstrong data-end=\"8856\" data-start=\"8838\"\u003epre\/probiotics\u003c\/strong\u003e to stabilize bile-acid pools and intestinal barrier.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"8914\" data-start=\"8911\"\u003e\n\u003ch3 data-end=\"8939\" data-start=\"8916\"\u003eSelected References\u003c\/h3\u003e\n\u003cul data-end=\"9888\" data-start=\"8941\"\u003e\n\u003cli data-end=\"9071\" data-start=\"8941\"\u003e\n\u003cp data-end=\"9071\" data-start=\"8943\"\u003e\u003cstrong data-end=\"9001\" data-start=\"8943\"\u003eHepatology; Journal of Hepatology; Liver International\u003c\/strong\u003e — TUDCA\/UDCA in NAFLD and cholestasis; enzyme and imaging outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9204\" data-start=\"9072\"\u003e\n\u003cp data-end=\"9204\" data-start=\"9074\"\u003e\u003cstrong data-end=\"9134\" data-start=\"9074\"\u003eDiabetes; Journal of Clinical Endocrinology \u0026amp; Metabolism\u003c\/strong\u003e — Human insulin-sensitivity improvements and mechanistic signaling.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9336\" data-start=\"9205\"\u003e\n\u003cp data-end=\"9336\" data-start=\"9207\"\u003e\u003cstrong data-end=\"9261\" data-start=\"9207\"\u003eNeurology; Annals of Neurology; Movement Disorders\u003c\/strong\u003e — ALS\/PD\/HD trials and biomarker studies with tauroursodeoxycholic acid.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9465\" data-start=\"9337\"\u003e\n\u003cp data-end=\"9465\" data-start=\"9339\"\u003e\u003cstrong data-end=\"9414\" data-start=\"9339\"\u003eInvestigative Ophthalmology \u0026amp; Visual Science; Experimental Eye Research\u003c\/strong\u003e — Retinal protection and photoreceptor survival.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9560\" data-start=\"9466\"\u003e\n\u003cp data-end=\"9560\" data-start=\"9468\"\u003e\u003cstrong data-end=\"9493\" data-start=\"9468\"\u003eGut; Gastroenterology\u003c\/strong\u003e — Bile-acid–microbiome interactions, intestinal barrier effects.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9671\" data-start=\"9561\"\u003e\n\u003cp data-end=\"9671\" data-start=\"9563\"\u003e\u003cstrong data-end=\"9610\" data-start=\"9563\"\u003eCell Death \u0026amp; Disease; Journal of Physiology\u003c\/strong\u003e — ER-stress, mitochondrial, and anti-apoptotic mechanisms.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9785\" data-start=\"9672\"\u003e\n\u003cp data-end=\"9785\" data-start=\"9674\"\u003e\u003cstrong data-end=\"9716\" data-start=\"9674\"\u003eAlimentary Pharmacology \u0026amp; Therapeutics\u003c\/strong\u003e — Clinical use patterns and tolerability in hepatobiliary disease.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9888\" data-start=\"9786\"\u003e\n\u003cp data-end=\"9888\" data-start=\"9788\"\u003e\u003cstrong data-end=\"9819\" data-start=\"9788\"\u003eObesity Surgery; Metabolism\u003c\/strong\u003e — Post-bariatric metabolic\/bile-acid changes and TUDCA adjunction.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"RCpeptides","offers":[{"title":"Default Title","offer_id":52684850921810,"sku":null,"price":60.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/tudca500mg.png?v=1770834838","url":"https:\/\/sciencepeptideslab.com\/products\/tudca-100x500mg","provider":"Science Peptides Lab","version":"1.0","type":"link"}